Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,705.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 1,839.00
  • 52 Week Low: 1,191.00
  • Currency: UK Pounds
  • Shares Issued: 208.75m
  • Volume: 17,776
  • Market Cap: £3,559.15m
  • RiskGrade: 125
  • Beta: 0.00

Latest ShareCast News

ViiV Healthcare's Rebecca Hall to join Hikma as CFO

By Abigail Townsend

Date: Thursday 24 Sep 2026

(Sharecast News) - Hikma Pharmaceuticals has named Rebecca Hall chief executive, the generic drugs specialist confirmed on Thursday.

HIK Regulatory News

Holding(s) in Company 21-Oct-2026 14:57 RNS
Holding(s) in Company 20-Oct-2026 14:46 RNS
Hikma appoints Rebecca Hall as CFO 24-Sep-2026 07:00 RNS
Hikma R&D Investor Spotlight Series 22-Sep-2026 12:00 RNS
Director/PDMR Shareholding 22-Sep-2026 09:32 RNS

HIK News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,705.00p
Change Today 5.00p
% Change 0.29 %
52 Week High 1,839.00
52 Week Low 1,191.00
Volume 17,776
Shares Issued 208.75m
Market Cap £3,559.15m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.8% below the market average3.8% below the market average3.8% below the market average3.8% below the market average3.8% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
81.16% below the market average81.16% below the market average81.16% below the market average81.16% below the market average81.16% below the market average
44.19% below the sector average44.19% below the sector average44.19% below the sector average44.19% below the sector average44.19% below the sector average
Income
60.36% above the market average60.36% above the market average60.36% above the market average60.36% above the market average60.36% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
35.74% above the market average35.74% above the market average35.74% above the market average35.74% above the market average35.74% above the market average
64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 13-Aug-26 19-Mar-26
Paid 17-Sep-26 30-Apr-26
Amount 38.00¢ 48.00¢

Trades for 27-Oct-2026

Time Volume / Share Price
12:17 1 @ 1,706.00p
12:17 3 @ 1,706.00p
12:17 1 @ 1,706.00p
12:17 1 @ 1,706.00p
12:17 3 @ 1,706.00p

HIK Key Personnel

CEO Said Darwazah
Chair Victoria Hull

Top of Page